ArticleScientific reports2023

Lonafarnib and everolimus reduce pathology in iPSC-derived tissue engineered blood vessel model of Hutchinson-Gilford Progeria Syndrome.

Nadia O Abutaleb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.